Eurofarma
Rodrigo Pereira is a seasoned executive specializing in business development, corporate ventures, and digital innovation. Currently serving as the Global Executive Director at Eurofarma since August 2022, Rodrigo previously held various leadership roles, including Director of Business Development at B3, where significant investments exceeding USD 100 million in over 60 fintech companies were made, and the establishment of the "B3 CVC Tech Fund." Rodrigo's extensive experience also includes directing Fintech initiatives at ACATE and leading corporate venture programs at Cetip, where expertise in structuring investments, strategic partnerships, and managing investor relations was demonstrated. Rodrigo holds an MBA in Finance and a Bachelor's degree in Industrial Engineering.
This person is not in any teams
This person is not in any offices
Eurofarma
5 followers
Since its establishment in 1972, Eurofarma has been operating in the health industry, producing and marketing products and services to improve people's quality of life. Focused on generating shared value, it operates in the areas of Prescription, Nos-Prescription, Generics, Hospital and Oncology. It offers over 700 products, over 2,000 SKUs and serves 42 medical specialties. In Brazil, it covers 100 therapeutic classes, which represent 70% of prescriptions in the entire market. Operating in 20 countries, with manufacturing facilities in Brazil and industrial parks in six other Latin American countries, it generated net sales of R$ 7.1 billion in 2021, a growth of 23% compared to the previous year, and employs more than 8,100 people.